ResMed Company Profile (NYSE:RMD)

Analyst Ratings

Consensus Ratings for ResMed (NYSE:RMD) (?)
Ratings Breakdown: 2 Sell Rating(s), 6 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: C$58.93 (10.62% downside)

Analysts' Ratings History for ResMed (NYSE:RMD)
Show:
DateFirmActionRatingPrice TargetActions
7/10/2016Bank of America Corp.Reiterated RatingHold$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Needham & Company LLCDowngradeHold -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016BMO Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016MacquarieUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Citigroup Inc.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Piper Jaffray Cos.DowngradeOverweight -> Neutral$65.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016Barclays PLCInitiated CoverageUnderweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Credit Suisse Group AGUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Deutsche Bank AGUpgradeSell -> Hold$53.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015Goldman Sachs Group Inc.UpgradeNeutral -> Conviction-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Jefferies GroupSet Price TargetHold$65.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015Northland SecuritiesBoost Price TargetHold -> Under Perform$40.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for ResMed (NYSE:RMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016Q416$0.74$512.37 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q316$0.69$0.68$455.32 million$453.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016Q216$0.66$0.69$445.46 million$454.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q116$0.59$0.58$406.26 million$411.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q415$0.65$0.68$436.27 million$453.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q315$0.65$0.65$425.76 million$422.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2015Q215$0.62$0.64$408.20 million$423.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q115$0.58$0.58$375.00 million$380.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q414$0.66$0.64$433.42 million$415.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q314$0.64$0.63$401.00 million$397.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2014Q214$0.63$0.60$398.09 million$384.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q114$0.58$0.56$372.28 million$357.66 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q4 2013$0.62$0.62$410.89 million$414.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q3 2013$0.58$0.58$386.76 million$383.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2013Q2 2013$0.51$0.53$363.76 million$376.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$0.46$0.49ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.49$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.41$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$0.38$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2011$0.35$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.37$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.35$0.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.36$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ResMed (NYSE:RMD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.70$0.73$0.72
Q2 20162$0.75$0.75$0.75
Q3 20161$0.68$0.68$0.68
Q4 20163$0.74$0.76$0.75
Q1 20172$0.68$0.77$0.73
Q2 20172$0.75$0.82$0.79
Q3 20171$0.75$0.75$0.75
Q4 20171$0.80$0.80$0.80
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for ResMed (NYSE:RMD)
Annual Dividend:$1.20
Dividend Yield:1.82%
Payout Ratio:48.98% (Based on Trailing 12 Months of Earnings)
45.45% (Based on Current Year Consensus EPS Estimate)
40.96% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:50.50% (3 Year Average)

Dividend History for ResMed (NYSE:RMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/26/2016quarterlyC$0.302.12%5/17/20165/19/20166/16/2016Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016quarterlyC$0.302.08%2/9/20162/11/20163/17/2016Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015quarterlyC$0.302.13%11/17/201511/19/201512/17/2015Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015quarterlyC$0.302.07%8/18/20158/20/20159/17/2015Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015quarterlyC$0.281.7%5/19/20155/21/20156/18/2015Tweet This Announcement  Share This Announcement on StockTwits
1/23/2015quarterlyC$0.281.72%2/10/20152/12/20153/19/2015Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014quarterlyC$0.282.17%11/18/201411/20/201412/18/2014Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014quarterlyC$0.282.25%8/19/20148/21/20149/18/2014Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014quarterlyC$0.252.11%5/16/20145/20/20146/17/2014Tweet This Announcement  Share This Announcement on StockTwits
1/24/2014quarterlyC$0.252.28%2/14/20142/19/20143/19/2014Tweet This Announcement  Share This Announcement on StockTwits
10/25/2013quarterlyC$0.252.02%11/15/201311/19/201312/18/2013Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013quarterlyC$0.252.09%8/16/20138/20/20139/17/2013Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013quarterlyC$0.171.44%5/17/20135/21/20136/18/2013Tweet This Announcement  Share This Announcement on StockTwits
1/25/2013quarterlyC$0.171.41%2/14/20132/19/20133/19/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for ResMed (NYSE:RMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/15/2016Michael J FarrellCEOSell5,975C$65.03C$388,554.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2016James HollingsheadInsiderSell2,753C$65.02C$179,000.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2016Peter C FarrellDirectorSell20,000C$63.62C$1,272,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016David PendarvisInsiderSell6,000C$63.62C$381,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016James HollingsheadInsiderSell4,458C$59.40C$264,805.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Michael J FarrellCEOSell5,975C$59.63C$356,289.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Peter C FarrellDirectorSell20,000C$59.82C$1,196,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016David PendarvisInsiderSell6,000C$59.41C$356,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Michael J FarrellCEOSell5,975C$57.64C$344,399.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Peter C FarrellDirectorSell20,000C$55.90C$1,118,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016David PendarvisInsiderSell6,000C$56.02C$336,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016Michael J FarrellCEOSell5,975C$59.34C$354,556.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016David PendarvisInsiderSell6,000C$58.70C$352,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Peter C FarrellDirectorSell20,000C$57.51C$1,150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016James HollingsheadInsiderSell4,500C$58.57C$263,565.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Michael J FarrellCEOSell5,975C$58.57C$349,955.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Gary W PaceDirectorSell36,000C$60.00C$2,160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Peter C FarrellDirectorSell20,000C$57.51C$1,150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016David PendarvisInsiderSell6,000C$57.26C$343,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Anne ReiserInsiderSell1,946C$57.06C$111,038.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Brett SandercockCFOSell30,000C$57.61C$1,728,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Richard SulpizioDirectorSell36,000C$57.88C$2,083,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Peter C FarrellDirectorSell139,980C$57.31C$8,022,253.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Michael J. FarrellCEOSell5,975C$58.20C$347,745.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2016Peter C. FarrellDirectorSell20,000C$57.70C$1,154,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016David PendarvisinsiderSell6,000C$57.43C$344,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2016Franz KozichDirectorBuy60,000C$0.04C$2,100.00Tweet This Trade  Share This Trade on StockTwits
1/15/2016Michael J. FarrellCEOSell5,975C$53.07C$317,093.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016David PendarvisinsiderSell6,000C$52.16C$312,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Peter C. FarrellDirectorSell20,000C$52.22C$1,044,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Robert Andrew DouglasCOOSell6,337C$52.97C$335,670.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015James HollingsheadInsiderSell4,500C$55.95C$251,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015David PendarvisinsiderSell6,000C$59.38C$356,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Robert Andrew DouglasCOOSell6,333C$59.77C$378,523.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Warren Russell HawkinsDirectorBuy15,000C$0.06C$825.00Tweet This Trade  Share This Trade on StockTwits
11/24/2015Warren Russell HawkinsDirectorBuy3,000C$0.06C$165.00Tweet This Trade  Share This Trade on StockTwits
11/20/2015Christopher G RobertsDirectorSell12,000C$59.03C$708,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Michael J. FarrellCEOSell5,975C$57.03C$340,754.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Donald DarkininsiderSell25,442C$57.72C$1,468,512.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Robert Andrew DouglasCOOSell6,333C$57.60C$364,780.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2015Anne ReiserinsiderSell3,000C$57.01C$171,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Michael J. FarrellCEOSell5,975C$55.35C$330,716.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015David PendarvisinsiderSell5,500C$52.47C$288,585.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Robert Andrew DouglasCOOSell6,333C$52.13C$330,139.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Peter C. FarrellChairmanSell27,169C$50.93C$1,383,717.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015James HollingsheadInsiderSell4,455C$50.67C$225,734.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Michael J. FarrellCEOSell5,975C$50.89C$304,067.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015David PendarvisinsiderSell5,500C$51.78C$284,790.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Robert Andrew DouglasCOOSell6,333C$52.04C$329,569.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Peter C. FarrellChairmanSell36,000C$50.82C$1,829,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015Anne ReiserinsiderSell6,000C$52.26C$313,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Richard SulpizioDirectorSell10,860C$51.83C$562,873.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Michael J FarrellCEOSell5,975C$55.54C$331,851.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Michael J FarrellCEOSell5,975C$57.59C$344,100.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015David PendarvisInsiderSell5,500C$55.19C$303,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Peter C FarrellChairmanSell36,000C$55.61C$2,001,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Robert Andrew DouglasCOOSell6,333C$56.59C$358,384.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Michael J FarrellCEOSell5,975C$57.87C$345,773.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015David PendarvisInsiderSell5,500C$59.41C$326,755.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Peter C FarrellChairmanSell36,000C$59.25C$2,133,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Robert Andrew DouglasCOOSell6,333C$59.22C$375,040.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015David PendarvisInsiderSell5,500C$65.10C$358,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015David PendarvisInsiderSell5,500C$72.60C$399,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Peter C FarrellChairmanSell36,000C$70.70C$2,545,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Robert Andrew DouglasCOOSell6,333C$70.67C$447,553.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Warren Russell HawkinsDirectorBuy10,000C$0.09C$900.00Tweet This Trade  Share This Trade on StockTwits
3/26/2015Warren Russell HawkinsDirectorBuy10,000C$0.08C$800.00Tweet This Trade  Share This Trade on StockTwits
3/16/2015Anne ReiserInsiderSell4,000C$69.10C$276,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Michael J FarrellCEOSell5,975C$69.10C$412,872.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Anne ReiserInsiderSell3,000C$66.75C$200,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Peter C FarrellChairmanSell36,000C$64.64C$2,327,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Robert Andrew DouglasCOOSell6,333C$64.39C$407,781.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Anne ReiserInsiderSell5,000C$66.11C$330,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015David PendarvisInsiderSell5,500C$62.35C$342,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015John P WarehamDirectorSell36,000C$63.49C$2,285,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Brett SandercockCFOSell18,670C$62.82C$1,172,849.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Robert Andrew DouglasCOOSell6,333C$62.35C$394,862.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Peter C FarrellChairmanSell36,000C$61.97C$2,230,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Gary W PaceDirectorSell48,000C$66.77C$3,204,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David PendarvisInsiderSell5,500C$57.09C$313,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Peter C FarrellChairmanSell36,000C$56.99C$2,051,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Robert Andrew DouglasCOOSell8,000C$56.99C$455,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Peter C FarrellChairmanSell36,000C$53.28C$1,918,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Robert Andrew DouglasCOOSell8,000C$52.93C$423,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Peter C FarrellChairmanSell36,000C$52.39C$1,886,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014David PendarvisInsiderSell3,557C$52.00C$184,964.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Robert Andrew DouglasCOOSell8,000C$51.84C$414,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Peter C FarrellChairmanSell119,204C$51.84C$6,179,535.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014David PendarvisInsiderSell5,000C$49.84C$249,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Robert Andrew DouglasCOOSell8,000C$49.11C$392,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Michael J FarrellCEOSell3,200C$52.41C$167,712.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Brett SandercockCFOSell10,000C$52.99C$529,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Brett SandercockCFOSell10,000C$53.23C$532,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014David PendarvisInsiderSell5,000C$53.23C$266,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Anne ReiserInsiderSell3,000C$53.37C$160,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014David PendarvisInsiderSell5,000C$49.12C$245,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Peter C FarrellDirectorSell25,000C$49.04C$1,226,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Robert Andrew DouglasCOOSell8,000C$48.95C$391,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Michael J FarrellCEOSell3,200C$49.22C$157,504.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2014David PendarvisInsiderSell5,000C$50.04C$250,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Peter C FarrellDirectorSell25,000C$50.09C$1,252,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Robert Andrew DouglasCOOSell8,000C$50.11C$400,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Michael J FarrellCEOSell3,200C$53.20C$170,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014David PendarvisInsiderSell5,000C$49.76C$248,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Peter C FarrellDirectorSell25,000C$49.57C$1,239,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Robert Andrew DouglasCOOSell8,000C$50.11C$400,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Christopher G RobertsDirectorSell25,000C$49.73C$1,243,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Michael FarrellCEOSell3,700C$50.54C$186,998.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014John WarehamDirectorSell18,000C$51.00C$918,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Brett SandercockCFOSell5,000C$50.00C$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Brett SandercockCFOSell4,290C$50.00C$214,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Peter FarrellDirectorSell25,000C$49.80C$1,245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Robert Andrew DouglasCOOSell8,000C$49.75C$398,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014David PendarvisInsiderSell15,000C$50.01C$750,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2014Peter FarrellDirectorSell75,000C$48.01C$3,600,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2014David PendarvisInsiderSell5,000C$44.95C$224,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Brett SandercockCFOSell10,687C$46.00C$491,602.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Peter FarrellDirectorSell25,000C$48.00C$1,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Robert Andrew DouglasCOOSell8,000C$49.10C$392,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013Brett SandercockCFOSell15,000C$51.06C$765,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013James HollingsheadInsiderSell4,000C$51.24C$204,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Donald DarkinInsiderSell31,063C$50.04C$1,554,392.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013David PendarvisInsiderSell37,744C$50.42C$1,903,052.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Peter C FarrellDirectorSell25,000C$53.21C$1,330,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Robert Andrew DouglasCOOSell8,000C$53.20C$425,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Gary W PaceDirectorSell12,000C$50.05C$600,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Peter C FarrellDirectorSell25,000C$48.00C$1,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Robert Andrew DouglasCOOSell8,000C$47.51C$380,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Michael QuinnDirectorSell48,000C$48.34C$2,320,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Brett SandercockCFOSell5,000C$49.00C$245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Christopher RobertsDirectorSell10,000C$49.49C$494,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Robert Andrew DouglasCOOSell8,000C$48.57C$388,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Robert Andrew DouglasCOOSell8,000C$47.96C$383,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Christopher G RobertsDirectorSell20,000C$49.45C$989,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013John P WarehamDirectorSell18,000C$50.20C$903,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Michael A QuinnDirectorSell15,000C$50.94C$764,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Brett SandercockCFOSell28,000C$48.97C$1,371,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Robert Andrew DouglasCOOSell8,000C$44.14C$353,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Michael J FarrellInsiderSell30,000C$35.58C$1,067,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ResMed (NYSE:RMD)
DateHeadline
07/23/16 09:59 AMQuick View of Earnings: Equinix, Inc. (NASDAQ:EQIX), ResMed Inc. (NYSE:RMD), Dycom Industries, Inc. (NYSE:DY ... - Engelwood Daily
07/23/16 09:59 AMFirms and Funds Increasing Their Stake in ResMed Inc. (NYSE:RMD) - Engelwood Daily
07/23/16 09:59 AMEquity Roundup: Stock Performance Focus on ResMed Inc. (NYSE:RMD) - Press Telegraph
07/23/16 09:59 AMResMed Inc. (NYSE:RMD) Current Analyst Ratings - Fiscal Standard
07/23/16 09:59 AMFriday Session Wrap-up for ResMed Inc. (NYSE:RMD) - Engelwood Daily
07/23/16 09:59 AMWhich way ResMed Inc. (NYSE:RMD) insiders are heading - Review Fortune
07/21/16 01:25 PMETF’s with exposure to ResMed, Inc. : July 21, 2016 -
07/21/16 08:59 AMAnalyst Consideration on this Stock: ResMed Inc. (NYSE:RMD) - News Oracle
07/21/16 08:59 AMResMed (RMD) Q4 Earnings: Disappointment in the Cards? - Nasdaq
07/20/16 09:00 AMLong Term Value Play: ResMed Inc. (NYSE:RMD) - TGP
07/20/16 09:00 AMStocks Trend Analysis: Newell Brands Inc. (NWL) ResMed Inc. (RMD) Sempra Energy (SRE) - iStreetWire
07/20/16 09:00 AMStock Strength in Focus for ResMed Inc. (NYSE:RMD) - Press Telegraph
07/19/16 07:08 AMEarnings Focus and Crowd Sourced Sentiment Review for ResMed Inc. (NYSE:RMD) - TGP
07/18/16 11:42 AMResMed Inc. (NYSE:RMD) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/18/16 11:42 AMOn the Move Insider Trading: ResMed Inc. (NYSE:RMD) - Post Registrar
07/17/16 10:16 AMHow Many ResMed Inc. (NYSE:RMD)'s Analysts Are Bearish? - Consumer Eagle
07/16/16 09:24 AMStock in Positive Territory for the Quarter: ResMed Inc. (NYSE:RMD) - Engelwood Daily
07/16/16 09:24 AMStock Notching a Recent High: ResMed Inc. (NYSE:RMD) - Press Telegraph
07/15/16 11:23 AMInstitutions are Increasing Positions in ResMed Inc. (NYSE:RMD) - Engelwood Daily
07/14/16 06:25 PMStock Wooing Investors After Increase: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/14/16 09:48 AMShares Rising to a Recent High: Resmed Inc.
07/13/16 06:34 PMResMed Inc. (NYSE:RMD) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 06:34 PMResMed Inc Realized Volatility Hits Elevated Level - CML News
07/13/16 06:34 PMInsiders are Gradually Selling ResMed Inc. (NYSE:RMD) - Telanagana Press
07/13/16 09:02 AMAnalyst Target and Average Rating Watch: ResMed Inc. (NYSE:RMD) - Press Telegraph
07/11/16 06:05 PMShares Positive on the Year: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/11/16 06:05 PMVan Hulzen Asset Management LLC Decreased Stake in Resmed (NYSE:RMD) by $3.01 Million as Shares Rose - Consumer Eagle
07/11/16 10:48 AMCan ResMed Inc. (NYSE:RMD) Improve on the Earnings Front? - Engelwood Daily
07/11/16 10:48 AMStock Performance Rundown on: ResMed Inc. (NYSE:RMD) - Press Telegraph
07/10/16 05:25 PMShare Valuation Recap for: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/09/16 05:31 PMHow Many ResMed Inc. (NYSE:RMD)'s Analysts Are Bearish? - Engelwood Daily
07/08/16 06:08 PMStock Showing Gains This Year: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/08/16 06:08 PMPerformance Recap and Target Perspective on ResMed Inc. (NYSE:RMD) - Press Telegraph
07/07/16 06:12 PMInsiders and Institutional Investors Selling ResMed Inc. Common Stock (NYSE:RMD)
07/07/16 06:12 PMChief Administrative Officer of ResMed Inc (NYSE:RMD), Pendarvis David, sells 6,000 shares worth $381,720
07/07/16 03:11 PMResMed to Announce Fourth Quarter Fiscal Year 2016 Results - [at noodls] - SAN DIEGO, July 7, 2016 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced it will report its fourth quarter of fiscal year 2016 results on Thursday, July 28, 2016 after the New York Stock Exchange ...
07/06/16 06:29 PMResMed Inc. (NYSE:RMD) Ratings in Focus - Stocks Daily
07/06/16 10:48 AMStock Strength Recap for ResMed Inc. (NYSE:RMD) - Press Telegraph
07/04/16 05:20 PMShares With YTD Gains: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/04/16 05:19 PMBroker Outlook For The Week Ahead ResMed Inc. (NYSE:RMD) - Fiscal Standard
07/03/16 10:18 AMStock Valuation in Review: ResMed Inc. (NYSE:RMD) - Telanagana Press
07/02/16 05:44 PMHow Analysts Feel About ResMed Inc. (NYSE:RMD)? - Engelwood Daily
07/02/16 05:44 PMShare Performance Recap for: ResMed Inc. (NYSE:RMD) - Press Telegraph
07/01/16 06:10 PMIs Resmed Inc (NYSE:RMD) Going to Burn These Institutional Investors? - Engelwood Daily
06/30/16 08:58 AMResMed Inc. (NYSE:RMD) Company Rating and Target Watch - Telanagana Press
06/29/16 08:54 AMMatthews International Capital Management LLC Increased Resmed INC (NYSE:RMD) by $69.41 Million as Shares Rose - Engelwood Daily
06/29/16 08:54 AMResMed Inc. (RMD) is Trading Lower on Unusual Volume for June 27 - Equities.com
06/28/16 06:03 PMResMed Inc. : Median Sales Estimate At $546.65
06/28/16 08:11 AMResMed Awarded Group Purchasing Contract with Premier - [at noodls] - SAN DIEGO, June 28, 2016 /PRNewswire/ -- ResMed (NYSE:RMD), the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced it has ...
06/28/16 07:02 AMTop Stock Pick for Quarter: ResMed Inc. (NYSE:RMD) - Engelwood Daily

Social

About ResMed

ResMed logoResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: RMD
  • CUSIP: 76115210
Key Metrics:
  • Previous Close: $65.93
  • 50 Day Moving Average: $62.26
  • 200 Day Moving Average: $58.59
  • P/E Ratio: 27.02
  • P/E Growth: 2.40
  • Market Cap: $9.26B
  • Beta: 0.64
  • Current Year EPS Consensus Estimate: $2.64 EPS
  • Next Year EPS Consensus Estimate: $2.93 EPS
Additional Links:
ResMed (NYSE:RMD) Chart for Saturday, July, 23, 2016